Stocktwits on MSN
Aurinia Pharma Stands By Lupus Drug After FDA Official’s Retracted Post Sparks 16% Selloff — Retail Stays Bullish On Recovery
Aurinia Pharmaceuticals on Monday pushed back on criticism of its lupus drug Lupkynis (voclosporin) by a top FDA official who had raised questions about the medicine’s clinical benefit in a LinkedIn ...
Health and Me on MSN
Selena Gomez Reveals Battling Finger Arthritis Caused By Lupus; Know How Lupus Affects Your Joints
Selena Gomez has long been open about her battle with lupus, an autoimmune disease in which the immune system mistakenly ...
Barrett Brooks and Ashlyn Sullivan break down the Eagles' injury issues with two weeks left until the season opener against the Cowboys.
A Gen Z woman returned from vacation with more than just memories—what she believed was a chlorine rash was something else entirely Reddit user u/survivorsavedmylife from New England came back from ...
Update Saturday: The person who was shot Friday night is a 35-year-old man who was shot in his right leg, Syracuse police said Saturday in a news release. When police arrived last night in the 100 ...
UCSF researchers have found that certain antiviral genes become less active over time in lupus, revealing why some patients see their symptoms fade as they age. Lupus, an autoimmune disease, causes ...
Serena Williams is serving up physical perfection. In photos shared to Instagram Thursday, the tennis great posed in a Monday Swimwear bikini top ($106), bottom ($90) and crochet skirt ($145) in a ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Maureen A. McMahon ...
Objective This study aims to evaluate the role of antiphospholipid antibodies (aPLs) in patients with SLE with heart valve diseases (HVDs). Methods This prospective study included consecutive patients ...
Cohort B of the Phase 2 study indicates all doses of enpatoran were associated with higher BICLA response rates compared with placebo, though the primary endpoint of BICLA dose-response relationship ...
An oral therapy targeting toll-like receptors (TLR) 7 and 8 reduced disease activity in patients with cutaneous lupus erythematosus (CLE) or systemic lupus erythematosus (SLE) with active lupus rash.
Photo courtesy of Mayo Clinic A 35-year-old man presents with a chief complaint of purple discoloration of his toes and associated skin lesions that have been present for the past month. A 35-year-old ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results